Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis


Kurt O. K. , Kurt B., Talay F., Tug T., Soy M., Bes C., ...Daha Fazla

WIENER KLINISCHE WOCHENSCHRIFT, cilt.125, ss.616-620, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 125
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00508-013-0417-0
  • Dergi Adı: WIENER KLINISCHE WOCHENSCHRIFT
  • Sayfa Sayıları: ss.616-620

Özet

The use of anti-TNF drugs for rheumatic diseases has increased in recent years. Several studies have reported an increased risk of reactivation of tuberculosis (TB) with anti-TNF agents.